
A Rockford city council member is pushing for local restrictions on 7-hydroxymitragynine (7-OH), a controversial chemical compound derived from kratom that has been linked to overdose deaths and prompted federal scrutiny. Alderman Tim Durkee's proposed ban cleared the city's code and regulation committee by a 3-2 vote on November 11, 2025, and now awaits a full council vote scheduled for November 17.
The move comes as the U.S. Food and Drug Administration recommended on July 29 that 7-OH be classified as a Schedule I substance, placing it in the same category as heroin and LSD due to its high potential for abuse. According to a memo from Rockford's assistant city attorney Jacob Rubin, the compound poses a "danger to the public health" and has been "found to be fatal" in high doses due to respiratory depression.
Durkee, who works as an obstetrician and gynecologist, expressed particular concern about the substance's potency and addictive properties. "It has a high dependency, high overdose. It's problematic," he stated, noting that the compound's ability to bind with opioid receptors may make it more powerful than morphine itself.
The proposed ordinance reflects a broader trend across the United States, with at least seven states, including Wisconsin, having already enacted bans on 7-OH products. Recent deaths linked to the substance include a fatal case in Columbus, Ohio, and three overdoses in Los Angeles County, underscoring the serious public health implications.
Unlike natural kratom leaf products, 7-OH is synthesized by chemists who concentrate a "tiny portion" of the kratom plant into significantly more potent versions available in tablets, flavored shots, and strips. Craig Katz, government relations and compliance manager for CBD Kratom, emphasized the distinction between natural kratom products and synthetic 7-OH, stating his company does not carry the compound. "We have to make sure that the consumers of our products are safe," Katz explained.
However, the proposal has met resistance from some local retailers. Steven Johnson, manager of Peace Novelty in Rockford, defended 7-OH products as providing pain relief for individuals who cannot access or afford prescription medications. Johnson advocated for regulation rather than prohibition, comparing the substance to socially acceptable products like alcohol while acknowledging its addictive potential.
The debate highlights the complex challenges facing municipalities as they attempt to address gaps in federal and state regulation of emerging substances in the supplement and botanical product space. Other Illinois communities, including Winnetka and Monticello, have also moved forward with local restrictions in recent months.
According to WIFR reporting, the 7-OH industry is estimated to be worth between $2 and $8 billion, creating significant financial incentives for retailers despite mounting safety concerns.
The Rockford case demonstrates how municipalities are stepping in where federal oversight remains incomplete, particularly for rapidly emerging compounds in the supplement and botanical product marketplace. As regulatory frameworks continue to evolve, businesses in highly regulated industries face increasing pressure to ensure product safety and compliance at every level.
Subscribe to Our Newsletter
Stay informed with daily insights on compliance, regulation, and industry trends.
Subscribe Here
Read Our Blog
Explore in-depth analysis and expert perspectives on navigating highly regulated industries.
Visit Our Blog
Reach Out to Learn More About Our Products
Discover how Q-Trust can strengthen your compliance framework and protect your business.
Contact Us